TickerRisk
Learn Pricing Open Scanner

BIIB vs BSX: Options Risk Comparison

BIOGEN INC. and BOSTON SCIENTIFIC CORP compared side by side — risk score, IV Rank, edge and earnings. Updated every 30 minutes.

MetricBIIBBSX
Risk Score8171
Risk BandHIGHHIGH
IV Rank75.264.4
IV %45.4%53.4%
Edge Score-6-7
Price Δ-3.0%-0.1%
Next Earnings2026-07-292026-07-29
SectorHealth CareHealth Care

Which has higher options risk?

BIOGEN INC. (BIIB) currently carries the higher options risk score (81 vs 71 for BSX) — meaning more active catalysts that can drive an overnight move. For selling option premium, BIOGEN INC. (BIIB) has the better edge score (-6) — a stronger blend of high IV Rank and low risk.

Risk score (0–100) reflects active catalysts — earnings, legal, SEC filings and news. Edge score = IV Rank − risk score; higher is better for selling premium.

Run a full scan on each — free

Scan BIIB → Scan BSX →

BIIB risk pages

More Health Care comparisons

TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer